Molecular Components and Functions of the Endocannabinoid System in Mouse Prefrontal Cortex
暂无分享,去创建一个
Pedro Grandes | Yamina Bakiri | O. Manzoni | M. Lafourcade | Y. Bakiri | Mathieu Lafourcade | P. Grandes | Olivier J. Manzoni | Susana Mato | Izaskun Elezgarai | I. Elezgarai | S. Mato
[1] D. Lovinger,et al. Induction of striatal long‐term synaptic depression by moderate frequency activation of cortical afferents in rat , 2005, The Journal of physiology.
[2] M. Kano,et al. Presynaptic Monoacylglycerol Lipase Activity Determines Basal Endocannabinoid Tone and Terminates Retrograde Endocannabinoid Signaling in the Hippocampus , 2007, The Journal of Neuroscience.
[3] T. Sejnowski,et al. Synaptic background noise controls the input/output characteristics of single cells in an in vitro model of in vivo activity , 2003, Neuroscience.
[4] P. Janak,et al. Neuronal and behavioral correlations in the medial prefrontal cortex and nucleus accumbens during cocaine self-administration by rats , 2000, Neuroscience.
[5] David Robbe,et al. Presynaptic Homeostatic Plasticity Rescues Long-Term Depression after Chronic Δ9-Tetrahydrocannabinol Exposure , 2005, The Journal of Neuroscience.
[6] Anatol C. Kreitzer,et al. Dopamine Modulation of State-Dependent Endocannabinoid Release and Long-Term Depression in the Striatum , 2005, The Journal of Neuroscience.
[7] David Robbe,et al. Localization and Mechanisms of Action of Cannabinoid Receptors at the Glutamatergic Synapses of the Mouse Nucleus Accumbens , 2001, The Journal of Neuroscience.
[8] L. Petrocellis,et al. Endocannabinoid signalling in the blood of patients with schizophrenia , 2003, Lipids in Health and Disease.
[9] H Ujike,et al. CNR1, central cannabinoid receptor gene, associated with susceptibility to hebephrenic schizophrenia , 2002, Molecular Psychiatry.
[10] H. Ujike,et al. New perspectives in the studies on endocannabinoid and cannabis: cannabinoid receptors and schizophrenia. , 2004, Journal of pharmacological sciences.
[11] J. Coyle,et al. Glutamatergic mechanisms in schizophrenia. , 2003, Annual review of pharmacology and toxicology.
[12] N. Griffon,et al. Schizophrenia and the cannabinoid receptor type 1 (CB1): association study using a single-base polymorphism in coding exon 1. , 2001, American journal of medical genetics.
[13] A. Hoffman,et al. Functional Tolerance and Blockade of Long-Term Depression at Synapses in the Nucleus Accumbens after Chronic Cannabinoid Exposure , 2003, The Journal of Neuroscience.
[14] M. Pistis,et al. Prefrontal Cortex Stimulation Induces 2-Arachidonoyl-Glycerol-Mediated Suppression of Excitation in Dopamine Neurons , 2004, The Journal of Neuroscience.
[15] T. Freund,et al. Role of endogenous cannabinoids in synaptic signaling. , 2003, Physiological reviews.
[16] P. Pacher,et al. The Endocannabinoid System as an Emerging Target of Pharmacotherapy , 2006, Pharmacological Reviews.
[17] P. Goldman-Rakic. Cellular basis of working memory , 1995, Neuron.
[18] A. Grace,et al. Cannabinoids Potentiate Emotional Learning Plasticity in Neurons of the Medial Prefrontal Cortex through Basolateral Amygdala Inputs , 2006, The Journal of Neuroscience.
[19] Masahiko Watanabe,et al. Localization of diacylglycerol lipase-alpha around postsynaptic spine suggests close proximity between production site of an endocannabinoid, 2-arachidonoyl-glycerol, and presynaptic cannabinoid CB1 receptor. , 2006, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[20] F. Conquet,et al. Immunolocalization of the mGluR1b Splice Variant of the Metabotropic Glutamate Receptor 1 at Parallel Fiber‐Purkinje Cell Synapses in the Rat Cerebellar Cortex , 2000, Journal of neurochemistry.
[21] David Robbe,et al. Endogenous cannabinoids mediate long-term synaptic depression in the nucleus accumbens , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[22] J. Sullivan,et al. Cannabinoid receptors , 2002, Current Biology.
[23] E. Fride. Endocannabinoids in the central nervous system: from neuronal networks to behavior. , 2005, Current drug targets. CNS and neurological disorders.
[24] D. Piomelli. The endocannabinoid system: a drug discovery perspective. , 2005, Current opinion in investigational drugs.
[25] Therese Garrick,et al. Selective antagonist [3H]SR141716A binding to cannabinoid CB1 receptors is increased in the anterior cingulate cortex in schizophrenia , 2004, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[26] P. Soubrié,et al. Cannabinoids modulate synaptic strength and plasticity at glutamatergic synapses of rat prefrontal cortex pyramidal neurons. , 2000, Journal of neurophysiology.
[27] Joseph E LeDoux,et al. New vistas on amygdala networks in conditioned fear. , 2004, Journal of neurophysiology.
[28] S. Charpier,et al. In vivo induction of striatal long-term potentiation by low-frequency stimulation of the cerebral cortex , 1999, Neuroscience.
[29] Tiziana Bisogno,et al. Depolarization‐induced retrograde synaptic inhibition in the mouse cerebellar cortex is mediated by 2‐arachidonoylglycerol , 2006, The Journal of physiology.
[30] David Robbe,et al. A single in-vivo exposure to delta 9THC blocks endocannabinoid-mediated synaptic plasticity. , 2004, Nature neuroscience.
[31] Wade G. Regehr,et al. Endocannabinoids Control the Induction of Cerebellar LTD , 2005, Neuron.
[32] Judit K. Makara,et al. Selective inhibition of 2-AG hydrolysis enhances endocannabinoid signaling in hippocampus , 2005, Nature Neuroscience.
[33] P. Soubrié,et al. Direct and indirect interactions between cannabinoid CB1 receptor and group II metabotropic glutamate receptor signalling in layer V pyramidal neurons from the rat prefrontal cortex , 2003, The European journal of neuroscience.
[34] Michael Davis,et al. Enhancing Cannabinoid Neurotransmission Augments the Extinction of Conditioned Fear , 2005, Neuropsychopharmacology.
[35] David Robbe,et al. A single in-vivo exposure to Δ9THC blocks endocannabinoid-mediated synaptic plasticity , 2004, Nature Neuroscience.
[36] Masahiko Watanabe,et al. Subcellular Arrangement of Molecules for 2-Arachidonoyl-Glycerol-Mediated Retrograde Signaling and Its Physiological Contribution to Synaptic Modulation in the Striatum , 2007, The Journal of Neuroscience.
[37] Ralitza Gueorguieva,et al. Delta-9-tetrahydrocannabinol effects in schizophrenia: Implications for cognition, psychosis, and addiction , 2005, Biological Psychiatry.
[38] W. Zieglgänsberger,et al. The endogenous cannabinoid system controls extinction of aversive memories , 2002, Nature.
[39] A. Grace,et al. The roles of cannabinoid and dopamine receptor systems in neural emotional learning circuits: implications for schizophrenia and addiction , 2006, Cellular and Molecular Life Sciences CMLS.
[40] T. Freund,et al. Cannabinoid CB1 receptor dependent effects of the NMDA antagonist phencyclidine in the social withdrawal model of schizophrenia , 2005, Behavioural pharmacology.
[41] A. Ghodse,et al. Cannabis and psychotic illness , 1992, British Journal of Psychiatry.
[42] R Lujan,et al. Perisynaptic Location of Metabotropic Glutamate Receptors mGluR1 and mGluR5 on Dendrites and Dendritic Spines in the Rat Hippocampus , 1996, The European journal of neuroscience.
[43] J. Bockaert,et al. Complex interactions between mGluRs, intracellular Ca2+ stores and ion channels in neurons , 2000, Trends in Neurosciences.
[44] A. Hoffman,et al. Direct actions of cannabinoids on synaptic transmission in the nucleus accumbens: a comparison with opioids. , 2001, Journal of neurophysiology.
[45] Ken Mackie,et al. Cannabinoid receptors as therapeutic targets. , 2006, Annual review of pharmacology and toxicology.
[46] R. Dingledine,et al. Functional interactions between cannabinoid and metabotropic glutamate receptors in the central nervous system. , 2003, Current opinion in pharmacology.
[47] Kristen K. Ade,et al. Anandamide Regulates Postnatal Development of Long-Term Synaptic Plasticity in the Rat Dorsolateral Striatum , 2007, The Journal of Neuroscience.
[48] P. Worley,et al. A Single In Vivo Exposure to Cocaine Abolishes Endocannabinoid-Mediated Long-Term Depression in the Nucleus Accumbens , 2004, The Journal of Neuroscience.
[49] Michael Davis,et al. Systems-Level Reconsolidation Reengagement of the Hippocampus with Memory Reactivation , 2002, Neuron.
[50] K. Mackie,et al. Stimulation of Endocannabinoid Formation in Brain Slice Cultures through Activation of Group I Metabotropic Glutamate Receptors , 2005, Molecular Pharmacology.
[51] R. Carelli,et al. Nucleus accumbens cell firing during maintenance, extinction, and reinstatement of cocaine self-administration behavior in rats , 2000, Brain Research.
[52] K. Mackie,et al. Depolarization‐induced suppression of excitation in murine autaptic hippocampal neurones , 2005, The Journal of physiology.
[53] H. Emrich,et al. Elevated endogenous cannabinoids in schizophrenia. , 1999, Neuroreport.
[54] T. Freund,et al. Molecular Composition of the Endocannabinoid System at Glutamatergic Synapses , 2006, The Journal of Neuroscience.
[55] Vivien Chevaleyre,et al. Endocannabinoid-mediated synaptic plasticity in the CNS. , 2006, Annual review of neuroscience.
[56] Joachim Klosterkötter,et al. Cerebrospinal Anandamide Levels are Elevated in Acute Schizophrenia and are Inversely Correlated with Psychotic Symptoms , 2004, Neuropsychopharmacology.
[57] 祐輝 橋本谷,et al. Phospholipase Cβ serves as a coincidence detector through its Ca[2+] dependency for triggering retrograde endocannabinoid signal , 2005 .
[58] B. Dean,et al. Studies on [3H]CP-55940 binding in the human central nervous system: regional specific changes in density of cannabinoid-1 receptors associated with schizophrenia and cannabis use , 2001, Neuroscience.
[59] Hee-Sup Shin,et al. Phospholipase Cβ Serves as a Coincidence Detector through Its Ca2+ Dependency for Triggering Retrograde Endocannabinoid Signal , 2005, Neuron.
[60] D. Piomelli. The molecular logic of endocannabinoid signalling , 2003, Nature Reviews Neuroscience.
[61] D. Fortin,et al. Differential effects of endocannabinoids on glutamatergic and GABAergic inputs to layer 5 pyramidal neurons. , 2006, Cerebral cortex.